Genesis Startup Competition Pitch
summary
Nanyang Biologics claims a proprietary model, DTIGN, that predicts compound–protein interactions using 3D data and graph neural networks and benchmarks 27% more accurate on bioactivity than prior methods. The pipeline scans a >50,000 tropical plant library, shortlisted candidates in four months for a Japanese Tobacco project that generates “a few hundred thousand” in revenue. Business model is two-stage: near-term natural-product deals and SaaS/milestone/revenue-share pharma partnerships, with ecosystem partners Nvidia and Equinix bundling hardware+software.
AI-written summary · about
chapters (6)
- 0:00Introduction and company overview
- 1:53AI model DTIGN and demo
- 3:19Revenue model and commercialization
- 5:29Case study with Japanese Tobacco
- 6:32Roadmap and future milestones
- 7:13Q&A session
related talks
06mGenesis Startup Competition Pitch - Drylab AI
39mThe Translation Gap
05mGenesis Startup Competition Pitch - NunoX Tech
25mBiology's ChatGPT Moment
10mGenesis Startup Competition Pitch: NeuroMesh
36mKeynote: Scientific Discovery: From the Lab Bench to the GPU
40mGraph neural networks for biomedical insights
20mTranslating a Trillion Pointo Diseases of Data into Therapies